positive
1 day agoWockhardt Shares Surge 27% in Two Days Following US FDA Acceptance of Zaynich NDA
Wockhardt's stock price jumped 6.5% on December 2, extending its rally after the United States Food and Drug Administration (US FDA) accepted its New Drug Application (NDA) for the novel antibiotic Zaynich. The two-day surge, which includes a 19.21% jump on December 1, has propelled Wockhardt's stock up by nearly 27%
Companies:
- Wockhardt
Tags:
- Wockhardt
- stock market
positive
1 day agoWockhardt Shares Surge 27% in Two Days Following US FDA Acceptance of Zaynich NDA
Wockhardt's stock price jumped 6.5% on December 2, extending its rally after the United States Food and Drug Administration (US FDA) accepted its New Drug Application (NDA) for the novel antibiotic Zaynich. The two-day surge, which includes a 19.21% jump on December 1, has propelled Wockhardt's stock up by nearly 27%
Companies:
- Wockhardt
Tags:
- Wockhardt
- stock market
1 min read
51 words
Wockhardt stock jumps 27% in two days following US FDA acceptance of NDA for its breakthrough antibiotic Zaynich, marking a historic achievement.
Wockhardt's stock price jumped 6.5% on December 2, extending its rally after the United States Food and Drug Administration (US FDA) accepted its New Drug Application (NDA) for the novel antibiotic Zaynich. The two-day surge, which includes a 19.21% jump on December 1, has propelled Wockhardt's stock up by nearly 27%
Wockhardt's stock price jumped 6.5% on December 2, extending its rally after the United States Food and Drug Administration (US FDA) accepted its New Drug Application (NDA) for the novel antibiotic Zaynich. The two-day surge, which includes a 19.21% jump on December 1, has propelled Wockhardt's stock up by nearly 27%
Companies:
- Wockhardt
Tags:
- Wockhardt
- stock market
- Wockhardt
- stock market
- FDA approval
- Zaynich
- pharmaceuticals
Dec 2, 2025 • 08:15